Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.

ClinicalTrials.gov 1 recruiting now early-phase tilt small index

Chronic Pruritus of Unknown Origin: early-phase trial registry

1 of 1 indexed Chronic Pruritus of Unknown Origin trials are currently recruiting, with more weight in Phase 1-2.

Corpus placement: #11,370 of 28,707 conditions by registered trial count.

1 US clinical trials · 1 currently recruiting · #11,370 of 28,707 conditions by registered trial count

Chronic Pruritus of Unknown Origin: 1 US clinical trial tracked, 1 recruiting.

Chronic Pruritus of Unknown Origin is the subject of 1 registered US clinical trials on ClinicalTrials.gov, 1 of them currently open to new participants. 0 are in Phase 3-4 (later-stage) and 1 in Phase 1-2 (earlier-stage). The most active sponsor is Galderma R&D, running 1 of these trials.

Enrollment posture brief

Registry condition chronic-pruritus-of-unknown-origin

OPEN 1 | RECR 100% | LATE 0 | EARLY 1 | RANK #11370 | SPON 1

Nearest open-share peer: Aortic Arch Aneurysm (100% recruiting · 5 trials)

Chronic Pruritus of Unkn (th…100%Ablation80%ACL Reconstruction80%Abuse, Drug60%Acceptability60%
Open-enrollment share among volume-matched conditions near Chronic Pruritus of Unknown Origin

Chronic Pruritus of Unknown Origin lists 1 open slots (100% of 1 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →

Key findings

What ClinicalTrials.gov does not surface for Chronic Pruritus of Unknown Origin on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.

  1. Chronic Pruritus of Unknown Origin is recruiting above its size-band peers.

    1 of 1 indexed trials (100%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.

Phase 21

Phase Distribution

PhaseTrial count
Phase 2 1

Top Sponsors

Galderma R&D 1 trials

Named interventions

Most-linked intervention names on Chronic Pruritus of Unknown Origin records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.

nemolizumab Drug
1 trials
Placebo Drug
1 trials

US sites by state

Facility locations filed on Chronic Pruritus of Unknown Origin trials. A trial with sites in several states counts in each.

West Virginia 1 trials
Virginia 1 trials
Texas 1 trials
Pennsylvania 1 trials
Oregon 1 trials
New York 1 trials
Nevada 1 trials
North Dakota 1 trials

Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.

What to do with this Chronic Pruritus of Unknown Origin page

1 registered trials, 1 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.

  • 1 Chronic Pruritus of Unknown Origin trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
  • Galderma R&D sponsors the most Chronic Pruritus of Unknown Origin trials on record, review their full trial history before evaluating a specific study. See Galderma R&D's trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Chronic Pruritus of Unknown Origin condition card totals 1 registered trials; most-linked intervention nemolizumab; top US site state West Virginia. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.